Cargando…
Systematic analysis of overall survival and interactions between tumor mutations and drug treatment
BACKGROUND: Few exceptional responses in cancer treatment were attributed to a genetic predisposition of the tumor. METHODS: We analyzed a cohort of 3105 patients from 12 different cancer types and systematically sought the existence of a correlation between overall survival and the interaction of 2...
Autores principales: | Gatto, Francesco, Nielsen, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774108/ https://www.ncbi.nlm.nih.gov/pubmed/26936071 http://dx.doi.org/10.1186/s13045-016-0249-2 |
Ejemplares similares
-
Is there hope in improving 5-year overall survival?—review of 5-year overall survival data from KEYNOTE-001
por: Akingbemi, Wisdom, et al.
Publicado: (2020) -
Nomograms to predict overall survival for patients with endometrial carcinosarcoma
por: Iavazzo, Christos, et al.
Publicado: (2023) -
Expression of markers of neural stem and progenitor cells in glioblastoma multiforme in relation to tumor recurrence and overall survival
por: Wańkowicz, Paweł, et al.
Publicado: (2020) -
Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations
por: Krawczyk, Paweł, et al.
Publicado: (2015) -
Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
por: Han, Kelong, et al.
Publicado: (2015)